Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition

被引：0
|
作者：
Amy D Guertin
Melissa M Martin
Brian Roberts
Melissa Hurd
Xianlu Qu
Nathan R Miselis
Yaping Liu
Jing Li
Igor Feldman
Yair Benita
Andrew Bloecher
Carlo Toniatti
Stuart D Shumway
机构：
[1] Merck Research Laboratories,Department of Oncology
[2] Amgen,Department of In Vivo Pharmacology
[3] Hudson Alpha Institute,Molecular Biomarkers
[4] Merck Research Laboratories,Screening and Protein Sciences
[5] Merck Research Laboratories,Informatics and Analysis
[6] Merck Research Laboratories,undefined
[7] Merck Research Laboratories,undefined
[8] Institute for Applied Cancer Science,undefined
来源：
Cancer Cell International | / 12卷
关键词：
LoVo Cell; Sensitive Cell Line; Checkpoint Kinase; CHK1 Inhibitor; CHK1 Kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] ATR/CHK1/WEE1 DEPENDENCY IN SRSF2-MUTATED MDS/AML
    Eldfors, Samuli
    Rai, Sumit
    Sharma, Vineet
    Hossan, Tareq
    Cabrera, Claudia
    Bertino, Amy
    Gilbert, Angelique
    Walter, Matthew
    Porkka, Kimmo
    Graubert, Timothy
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [32] ATR/CHK1/WEE1 Dependency in SRSF2-Mutated MDS/AML
    Eldfors, Samuli
    Rai, Sumit
    Sharma, Vineet
    Gilbert, Angelique N.
    Porkka, Kimmo
    Graubert, Timothy A.
    BLOOD, 2021, 138 : 3661 - +
  • [33] Combined Inhibition of ChK1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients
    Bruyer, Angelique
    de Boussac, Hugues
    Martin, Thibaut
    Kassambara, Alboukadel
    Robert, Nicolas
    Cartron, Guillaume
    Hose, Dirk
    Seckinger, Anja
    Pasero, Philippe
    Moreaux, Jerome
    BLOOD, 2017, 130
  • [34] Chk1 and Wee1 kinases coordinate DNA replication, chromosome condensation, and anaphase entry
    Fasulo, Barbara
    Koyama, Carol
    Yu, Kristina R.
    Homola, Ellen M.
    Hsieh, Tao S.
    Campbell, Shelagh D.
    Sullivan, William
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23 (06) : 1047 - 1057
  • [35] ATR/CHK1/WEE1 DEPENDENCY IN SRSF2-MUTATED MDS/AML
    Eldfors, Samuli
    Rai, Sumit
    Sharma, Vineet
    Hossan, Tareq
    Cabrera, Claudia
    Bertino, Amy
    Gilbert, Angelique
    Walter, Matthew
    Porkka, Kimmo
    Graubert, Timothy
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [36] Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma
    Russell, Mike R.
    Levin, Kirill
    Rader, JulieAnn
    Belcastro, Lili
    Li, Yimei
    Martinez, Daniel
    Pawel, Bruce
    Shumway, Stuart D.
    Maris, John M.
    Cole, Kristina A.
    CANCER RESEARCH, 2013, 73 (02) : 776 - 784
  • [37] Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells
    Mak, Joyce P. Y.
    Man, Wing Yu
    Chow, Jeremy P. H.
    Ma, Hoi Tang
    Poon, Randy Y. C.
    ONCOTARGET, 2015, 6 (25) : 21074 - 21084
  • [38] Inhibition of Chk1 and Wee1 as an effective therapeutic approach in diffuse large B cell lymphomas: A way to target Myc?
    Vagni, M.
    Restelli, V.
    Lupi, M.
    Damia, G.
    Carrassa, L.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S122 - S122
  • [39] Chk1 and WEE1 Inhibition Combine Synergistically and Represent a Novel Non-cytotoxic Combination in Acute Myeloid Leukemia
    Tibes, Raoul
    Chaudhuri, Leena
    Vincelette, Nicole D.
    Kohl, Brian D.
    Naylor, Ryan M.
    Flatten, Karen S.
    Peterson, Kevin L.
    McNally, Amanda
    Gojo, Ivana
    Karp, Judith E.
    Mesa, Ruben A.
    Sproat, Lisa O.
    Bogenberger, James M.
    Kaufmann, Scott H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S127 - S128
  • [40] CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
    Qi, Wenxiu
    Xie, Chengzhi
    Li, Chunhuai
    Caldwell, J. Timothy
    Edwards, Holly
    Taub, Jeffrey W.
    Wang, Yue
    Lin, Hai
    Ge, Yubin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
12345